Context-Dependent Modulation of Macrophage Plasticity by Cordycepin Drives Tumor Regression in Melanoma
Open Access
- 27 April 2026
- journal article
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 31 (4) , 52067
Abstract
Background and Aim: Cordycepin (CDC), an adenosine (ADO) analog from Cordyceps mushrooms, exhibits potent anti-tumor and immunomodulatory activities. However, the precise mechanisms governing its effects on macrophage plasticity remain poorly understood. This study aimed to isolate CDC from a high-yielding Cordyceps cultivar, validate its systemic anti-tumor efficacy, and elucidate the mechanobiological cues regulating CDC-driven macrophage functions under varying cell-density states. Experimental Procedure: CDC (>98% purity) was isolated and structurally characterized via nuclear magnetic resonance (NMR) and high-resolution electrospray ionization mass spectrometry (HR-ESI-MS). Primary bone marrow-derived macrophages and RAW264.7 cells, cultured under sparse (~30%) or confluent (100%) conditions, were treated with CDC or ADO. We evaluated cell viability, pro-inflammatory cytokine expression, and Nuclear Factor kappa B (NF-κB) p65 signaling, phagocytosis, and migration. The therapeutic potential of CDC-primed macrophages was assessed via in vitro melanoma co-culture and in vivo intratumoral adoptive transfer in B16F10 tumor-bearing mice. Key Results: Systemic administration of CDC significantly inhibited melanoma growth in vivo, promoting apoptosis, enhancing macrophage infiltration. We discovered that CDC regulates macrophage functions via a density-dependent “switch”: while CDC induced cytotoxicity in sparse cultures, it significantly augmented M1-like cytokine production in confluent states without compromising viability. This density-dependent activation was mediated by the A2A adenosine receptor (A2AR), triggering the Akt–NF-κB p65 signaling axis. Furthermore, CDC upregulated migration- and phagocytosis-associated genes, enhancing tumor cell clearance. Notably, intratumoral injection of CDC-primed macrophages markedly reduced tumor volume and size in vivo. Conclusions and Implications: CDC modulates macrophage activation through a unique mechanobiological switch. Under high-density conditions—mimicking the dense tumor microenvironment—CDC enhances A2AR-mediated NF-κB activation, boosting macrophage activation, recruitment, and phagocytosis to facilitate tumor regression. These findings establish CDC as a context-dependent immunomodulator capable of reprogramming macrophages toward a tumoricidal phenotype.Keywords
Funding Information
- National Research Foundation of Korea (RS-2025-00558072)
- National Research Foundation of Korea (RS-2021-NF000578)
This publication has 27 references indexed in Scilit:
- Macrophage polarization in the tumor microenvironment: Emerging roles and therapeutic potentialsBiomedicine & Pharmacotherapy, 2024
- Macrophage phenotypes and functions: resolving inflammation and restoring homeostasisTrends in Immunology, 2023
- Adenosine derivatives from Cordyceps exert antitumor effects against ovarian cancer cells through ENT1-mediated transport, induction of AMPK signaling, and consequent autophagic cell deathBiomedicine & Pharmacotherapy, 2022
- Cordycepin enhances anti-tumor immunity in colon cancer by inhibiting phagocytosis immune checkpoint CD47 expressionInternational Immunopharmacology, 2022
- Improving effect of cordycepin on insulin synthesis and secretion in normal and oxidative-damaged INS-1 cellsEuropean Journal of Pharmacology, 2022
- Macrophage M1/M2 polarizationEuropean Journal of Pharmacology, 2020
- Material stiffness influences the polarization state, function and migration mode of macrophagesActa Biomaterialia, 2019
- Anticancer and antimetastatic effects of cordycepin, an active component of Cordyceps sinensisJournal of Pharmacological Sciences, 2015
- Cordycepin induces apoptosis of C6 glioma cells through the adenosine 2A receptor-p53-caspase-7-PARP pathwayChemico-Biological Interactions, 2014
- Cordycepin inhibits lipopolysaccharide-induced inflammation by the suppression of NF-κB through Akt and p38 inhibition in RAW 264.7 macrophage cellsEuropean Journal of Pharmacology, 2006